DK0776899T3 - Mellemprodukter og deres anvendelse til fremstilling af N,N'-forbundne bisindolylmaleimider - Google Patents

Mellemprodukter og deres anvendelse til fremstilling af N,N'-forbundne bisindolylmaleimider

Info

Publication number
DK0776899T3
DK0776899T3 DK96308317T DK96308317T DK0776899T3 DK 0776899 T3 DK0776899 T3 DK 0776899T3 DK 96308317 T DK96308317 T DK 96308317T DK 96308317 T DK96308317 T DK 96308317T DK 0776899 T3 DK0776899 T3 DK 0776899T3
Authority
DK
Denmark
Prior art keywords
bisindolylmaleimides
intermediates
linked
preparation
linked bisindolylmaleimides
Prior art date
Application number
DK96308317T
Other languages
English (en)
Inventor
Margaret Mary Faul
Christine Ann Krumrich
Leonard Larry Winneroski Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21725638&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0776899(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0776899T3 publication Critical patent/DK0776899T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DK96308317T 1995-11-20 1996-11-18 Mellemprodukter og deres anvendelse til fremstilling af N,N'-forbundne bisindolylmaleimider DK0776899T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US734595P 1995-11-20 1995-11-20

Publications (1)

Publication Number Publication Date
DK0776899T3 true DK0776899T3 (da) 2000-07-10

Family

ID=21725638

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96308317T DK0776899T3 (da) 1995-11-20 1996-11-18 Mellemprodukter og deres anvendelse til fremstilling af N,N'-forbundne bisindolylmaleimider

Country Status (31)

Country Link
EP (1) EP0776899B1 (da)
JP (2) JP4100708B2 (da)
KR (1) KR100342142B1 (da)
CN (1) CN1066734C (da)
AR (2) AR004718A1 (da)
AT (1) ATE191219T1 (da)
AU (1) AU701659B2 (da)
BR (1) BR9611709A (da)
CA (1) CA2237401C (da)
CO (1) CO4750824A1 (da)
CZ (1) CZ150398A3 (da)
DE (1) DE69607443T2 (da)
DK (1) DK0776899T3 (da)
EA (1) EA000639B1 (da)
ES (1) ES2145978T3 (da)
GR (1) GR3033729T3 (da)
HU (1) HU225716B1 (da)
IL (1) IL124415A (da)
MX (1) MX9803791A (da)
MY (1) MY118946A (da)
NO (1) NO310195B1 (da)
NZ (1) NZ323282A (da)
PE (1) PE17998A1 (da)
PL (1) PL184728B1 (da)
PT (1) PT776899E (da)
TR (1) TR199800876T2 (da)
TW (1) TW371661B (da)
UA (1) UA56145C2 (da)
WO (1) WO1997019080A1 (da)
YU (1) YU49316B (da)
ZA (1) ZA969645B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2245029A1 (en) 1998-03-13 1999-09-13 University Of British Columbia Granulatimide compounds as g2 checkpoint inhibitors
ATE251624T1 (de) * 1998-03-13 2003-10-15 Univ British Columbia Granulatimide-derivate zur behandlung von krebs
US6127401A (en) 1998-06-05 2000-10-03 Cephalon, Inc. Bridged indenopyrrolocarbazoles
US6300106B1 (en) 2000-11-22 2001-10-09 Ppg Industries Ohio, Inc. Method of preparing 3-[2-{(Methylsulfonyl)oxy}-ethoxy ]-4-(triphenylmethoxy)-1-butanol, methane sulfonate
EP2181999A1 (en) 2008-11-03 2010-05-05 Zentiva, A.S. Method of manufacturing ruboxistarin
EP4504178A1 (en) * 2022-03-31 2025-02-12 4M Therapeutics Inc. N-desmethyl ruboxistaurin as kinase inhibitor
EP4654966A1 (en) * 2023-01-27 2025-12-03 Mellicell, Inc. Methods and compositions for treatment of obesity and diseases associated with fat cell enlargement

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
PL182124B1 (pl) * 1993-12-07 2001-11-30 Lilly Co Eli Nowe zwiazki oraz srodek farmaceutyczny przeznaczony do leczenia powiklan cukrzycowych lub do leczenia nowotworów PL PL PL PL PL PL PL PL
US5559228A (en) * 1995-03-30 1996-09-24 Eli Lilly And Company Synthesis of bisindolylmaleimides

Also Published As

Publication number Publication date
EP0776899A1 (en) 1997-06-04
ZA969645B (en) 1998-05-18
NO982105L (no) 1998-05-08
JP2008138006A (ja) 2008-06-19
TR199800876T2 (xx) 1998-08-21
NO310195B1 (no) 2001-06-05
PL184728B1 (pl) 2002-12-31
IL124415A0 (en) 1998-12-06
ES2145978T3 (es) 2000-07-16
EA000639B1 (ru) 1999-12-29
YU61096A (sh) 1999-03-04
HUP9901975A3 (en) 2000-01-28
NZ323282A (en) 1999-01-28
KR19990067600A (ko) 1999-08-25
KR100342142B1 (ko) 2002-08-22
HU225716B1 (en) 2007-07-30
JP2000500496A (ja) 2000-01-18
AU701659B2 (en) 1999-02-04
JP4100708B2 (ja) 2008-06-11
EP0776899B1 (en) 2000-03-29
DE69607443D1 (de) 2000-05-04
PL326753A1 (en) 1998-10-26
DE69607443T2 (de) 2000-08-10
CN1207740A (zh) 1999-02-10
BR9611709A (pt) 1999-02-23
MY118946A (en) 2005-02-28
UA56145C2 (uk) 2003-05-15
CA2237401A1 (en) 1997-05-29
HUP9901975A2 (hu) 1999-11-29
CZ150398A3 (cs) 1998-12-16
ATE191219T1 (de) 2000-04-15
AU7738896A (en) 1997-06-11
PE17998A1 (es) 1998-04-20
TW371661B (en) 1999-10-11
PT776899E (pt) 2000-08-31
EA199800368A1 (ru) 1998-12-24
IL124415A (en) 2003-11-23
MX9803791A (es) 1998-09-30
NO982105D0 (no) 1998-05-08
GR3033729T3 (en) 2000-10-31
CN1066734C (zh) 2001-06-06
AR004719A1 (es) 1999-03-10
WO1997019080A1 (en) 1997-05-29
AR004718A1 (es) 1999-03-10
CO4750824A1 (es) 1999-03-31
CA2237401C (en) 2003-10-21
YU49316B (sh) 2005-06-10

Similar Documents

Publication Publication Date Title
NO933434D0 (no) Piperidinderivater, deres fremstilling og anvendelse
DK1019358T4 (da) 3,3-diarylpropylaminer, deres anvendelse og fremstilling
NO912058D0 (no) Bioforlikelige membraner, deres fremstilling og anvendelse
NO954369L (no) Oksazolidindionderivater, deres fremstilling og anvendelse
NO983965D0 (no) Polymer-organoleire-kompositter og deres fremstilling
NO961160D0 (no) Cykliske forbindelser, deres fremstilling og anvendelse
IS4564A (is) Framleiðsla og kristalform af 2-methýl-thíeno-bensodíasepín
NO307513B1 (no) 2,8-disubstituert chinazolinon og anvendelse derav
NO972236D0 (no) Dihydropyrimidiner og anvendelse derav
DK0832104T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
NO972983D0 (no) Sulfonamider og deres anvendelse
NO964958D0 (no) Aluminium-scandiumlegeringer og deres anvendelse
NO910816D0 (no) Forbedrede betongblandinger og deres anvendelse.
DK0804078T3 (da) Sammensætning og anvendelse deraf
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO952575D0 (no) Flytende vanillinblanding, deres fremstilling og anvendelse
NO961721D0 (no) 2-oksetanon-limingsmidler, deres fremstilling og bruk
DK0898566T3 (da) Substituerede benzylaminer og anvendelse deraf til behandling af depression
NO940989D0 (no) Triazolkinoksalin-1,4-dioner og deres fremstilling og anvendelse
NO953673D0 (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
DK0690065T3 (da) Biphenyl-2,2'-diyl-bis-diphenylphosphiner, deres fremstilling og deres anvendelse
NO963723L (no) Flytepunktnedsettende tilsetningsstoffer og deres anvendelse
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
NO933435D0 (no) Piperidinderivater, deres fremstilling og anvendelse